Mark Chang

Background

About Mark Chang

Dr. Mark Chang is the founder of AGInception for Artificial General Intelligence Research. Previously, Chang served as Sr. Vice President, Strategic Statistical Consulting at Veristat, Vice President of Biometrics at AMAG Pharmaceuticals and director and scientific fellow at Millennium/Takeda Pharmaceuticals. Dr. Chang has over 20 years of experience as a statistician, experienced in NDA submissions and has extensive experience in interaction with regulatory agencies. Chang is a fellow of the American Statistical Association and an adjunct professor of Biostatistics at Boston University. He is a co-founder of the International Society for Biopharmaceutical Statistics, co-chair of the Biotechnology Industry Organization (BIO) Adaptive Design Working Group, and a member of the Multiregional Clinical Trial (MRCT) Expert Group. He was a member of Expert Panel for the Networks of Centres of Excellence (NCE) in Canada and a member of the PhRMA Adaptive Design and Biomarker Working Groups. Chang served as associate editor for statistical Journals. He published 12 books, including Foundation, Architecture, and Prototyping of Humanized AI, Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare, Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials, Monte Carlo Simulation for the Pharmaceutical Industry, Adaptive Design Theory and Implementation Using SAS and R, Adaptive Design Method for Clinical Trials, Modern Issues and Methods in Biostatistics, Paradoxes in Scientific Inference, and Principles of Scientific Methods.